1. A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection. (29th November 2015) Authors: Wilkinson, John; Ewart, Gary; Luscombe, Carolyn; McBride, Kristin; Ratanasuwan, Winai; Miller, Michelle; Murphy, Robert L. Journal: Journal of antimicrobial chemotherapy Issue: Volume 71:Number 3(2016:Mar.) Page Start: 731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells. Issue 1 (December 2016) Authors: Khoury, Gabriela; Ewart, Gary; Luscombe, Carolyn; Miller, Michelle; Wilkinson, John Journal: AIDS research and therapy Issue: Volume 13:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗